Embedded Files
Visiting Scientist
Visiting Scientist
Department of Pharmacology
Department of Pharmacology
University of California, San Diego
University of California, San Diego
9500 Gilman Drive
9500 Gilman Drive
La Jolla, CA 92093-0601
La Jolla, CA 92093-0601
For deliveries, add: BSB Room 4080
For deliveries, add: BSB Room 4080
Phone: (858)-534-8903
Phone: (858)-534-8903
Email: vmouchlis@ucsd.edu
Email: vmouchlis@ucsd.edu
Home Town: Nicosia, Cyprus
Home Town: Nicosia, Cyprus
Education
Education
Ph.D., Rational Design and Synthesis of Phospholipase A2 Inhibitors, University of Athens, Greece (2007-10)
M.Sc., Organic Synthesis and its Applications in the Chemical Industry, University of Athens, Greece (2005-07)
B.Sc., Chemistry, University of Athens, Greece (2001-05)
Publications
Publications
Mouchlis, V. D.; Mavromoustakos, T. M.; Kokotos, G., Design of new secreted phospholipase A2 inhibitors based on docking calculations by modifying the pharmacophore segments of the FPL67047XX inhibitor. J. Comput.-Aided Mol. Des. 2010, 24, 107-15. PMID: 20130961
Mouchlis, V. D.; Mavromoustakos, T. M.; Kokotos, G., Molecular docking and 3D-QSAR CoMFA studies on indole inhibitors of GIIA secreted phospholipase A2. J. Chem. Inf. Model. 2010, 50, 1589-1601. PMID: 20795712
Tzoupis, H.; Leonis, G.; Durdagi, S.; Mouchlis, V.; Mavromoustakos, T.; Papadopoulos, M. G., Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculations. J. Comput.-Aided Mol. Des. 2011, 25, 959-976. PMID: 21969102
Mouchlis, V. D.; Magrioti, V.; Barbayianni, E.; Cermak, N.; Oslund, R. C.; Mavromoustakos, T. M.; Gelb, M. H.; Kokotos, G., Inhibition of secreted phospholipases A2 by 2-oxoamides based on alpha-amino acids: Synthesis, in vitro evaluation and molecular docking calculations. Bioorg. Med. Chem. 2011, 19, 735-743. PMID: 21216150
Mouchlis, V. D.; Barbayianni, E.; Mavromoustakos, T. M.; Kokotos, G., The application of rational design on phospholipase A2 inhibitors. Curr. Med. Chem. 2011, 18, 2566-2582. PMID: 21568891
Mouchlis, V. D.; Michopoulou, V.; Constantinou-Kokotou, V.; Mavromoustakos, T.; Dennis, E. A.; Kokotos, G., Binding conformation of 2-oxoamide inhibitors to group IVA cytosolic phospholipase A2 determined by molecular docking combined with molecular dynamics. J. Chem. Inf. Model. 2012, 52, 243-254. PMID: 22196172
Mouchlis, V. D.; Melagraki, G.; Mavromoustakos, T.; Kollias, G.; Afantitis, A., Molecular modeling on pyrimidine-urea inhibitors of TNF-α production: an integrated approach using a combination of molecular docking, classification techniques, and 3D-QSAR CoMSIA. J. Chem. Inf. Model. 2012, 52, 711-723. PMID: 22360289
Zhang, L.; Sedykh, A.; Tripathi, A.; Zhu, H.; Afantitis, A.; Mouchlis, V. D.; Melagraki, G.; Rusyn, I.; Tropsha, A., Identification of putative estrogen receptor-mediated endocrine disrupting chemicals using QSAR- and structure-based virtual screening approaches. Toxicol. Appl. Pharmacol. 2013, 272, 67-76. PMC3775906
Bucher, D.; Hsu, Y. H.; Mouchlis, V. D.; Dennis, E. A.; McCammon, J. A., Insertion of the Ca2+-independent phospholipase A2 into a phospholipid bilayer via coarse-grained and atomistic molecular dynamics simulations. PLoS Comput. Biol. 2013, 9, e1003156. PMC3723492
Mouchlis, V. D.; Bucher, D.; McCammon, J. A.; Dennis, E. A., Membranes serve as allosteric activators of phospholipase A2, enabling it to extract, bind, and hydrolyze phospholipid substrates. PNAS 2015, 112, E516-E525. PMC4330758
Mouchlis, V. D.; Limnios, D.; Kokotou, M. G.; Barbayianni, E.; Kokotos, G.; McCammon, J. A.; Dennis, E. A., Development of potent and selective inhibitors for group VIA calcium-independent phospholipase A2 guided by molecular dynamics and structure-activity relationships. J. Med. Chem. 2016, 59, 4403-4414. PMC4946799
Mouchlis, V. D.; Morisseau, C.; Hammock, B. D.; Li, S.; McCammon, J. A.; Dennis, E. A., Computer-aided drug design guided by hydrogen/deuterium exchange mass spectrometry: A powerful combination for the development of potent and selective inhibitors of Group VIA calcium-independent phospholipase A2. Bioorg. Med. Chem. 2016, 24, 4801-4811. PMC5053890
Antonopoulou, G.; Magrioti, V.; Kokotou, M. G.; Nikolaou, A.; Barbayianni, E.; Mouchlis, V. D.; Dennis, E. A.; Kokotos, G., 2-Oxoamide inhibitors of cytosolic group IVA phospholipase A2 with reduced lipophilicity. Bioorg. Med. Chem. 2016, 24, 4544-4554. PMC5014611
Mouchlis, V. D.; Dennis, E. A., Membrane and inhibitor interactions of intracellular phospholipases A2. Adv. Biol. Regul. 2016, 61, 17-24. PMC4884535
Smyrniotou, A.; Kokotou, M. G.; Mouchlis, V. D.; Barbayianni, E.; Kokotos, G.; Dennis, E. A.; Constantinou-Kokotou, V., 2-Oxoamides based on dipeptides as selective calcium-independent phospholipase A2 inhibitors. Bioorg. Med. Chem. 2017, 25, 926-940. PMC5291822
Google Sites
Report abuse